CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
KneeAlign 2device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02695329
NCT02695329N/ACompleted

Randomized Controlled Study Comparing Vanguard With KneeAlign2 Navigational System Versus Vanguard Conventional

Zimmer Biomet·interventional·Posted Mar 1, 2016·Updated Feb 12, 2020

In Brief

A clinical study evaluating KneeAlign 2 for Osteoarthritis, Knee. Completed, enrolled 100 participants across 1 site.

Detailed Summary

Purpose of this study is to determine the effectiveness of the KneeAlign 2 system in terms of precise implant alignment by demonstrating that KneeAlign 2 provides better tibial alignment compared to conventional instruments

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesJapan
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 1, 2016
Enrollment StartMay 24, 2016
Primary CompletionOct 3, 2018
Study CompletionOct 26, 2018
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 10.3 years ago

Interventions

KneeAlign 2device

Patients suffering non-severe varus deformity Osteoarthritis will be enrolled and randomly assigned into one of two treatment groups. Patients in investigational group will be treated with total knee arthroplasty and the accelerometer-based navigational device. Patients in control group will be treated with total knee arthroplasty with conventional instrumentation.